Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Advocating for in-center hemodialysis patients via anonymous survey.  Medicine.  101:E30937. 2022
2022 Lactated Ringer's solution and risk of hyperkalemia in patients with reduced kidney function: Safety of Lactated Ringer's in kidney disease.  American Journal of the Medical Sciences.  364:433-443. 2022
2022 Counteraction of Myocardial Ferritin Heavy Chain Deficiency by Heme Oxygenase-1.  International Journal of Molecular Sciences.  23. 2022
2022 A Reproducible Mouse Model of Moderate CKD With Early Manifestations of Osteoblastic Transition of Cardiovascular System.  Frontiers in Physiology.  13. 2022
2021 VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity 2021
2021 Quantitative 3-dimensional imaging and tissue cytometry reveals lymphatic expansion in acute kidney injury.  Laboratory Investigation.  101:1186-1196. 2021
2021 Heme burden and ensuing mechanisms that protect the kidney: Insights from bench and bedside.  International Journal of Molecular Sciences.  22. 2021
2021 Expression of lactate dehydrogenase A and B isoforms in the mouse kidney 2021
2020 Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease 2020
2020 Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease.  British Journal of Pharmacology.  177:793-809. 2020
2020 Zinc Inhibits HIF-Prolyl Hydroxylase Inhibitor-Aggravated VSMC Calcification Induced by High Phosphate.  Frontiers in Physiology.  10. 2020
2020 Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques.  Oxidative Medicine and Cellular Longevity.  2020. 2020
2019 Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease.  Laboratory Investigation.  99:1376-1388. 2019
2019 Ferritin in kidney and vascular related diseases: Novel roles for an old player.  Pharmaceuticals.  12. 2019
2019 Potential role of H-Ferritin in mitigating valvular mineralization 2019
2019 Ferritin light chain confers protection against sepsis-induced inflammation and organ injury.  Frontiers in Immunology.  10. 2019
2019 Renal control of disease tolerance to malaria 2019
2017 Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury.  American Journal of Kidney Diseases.  69:531-545. 2017
2017 The disparate effect of hemodialysis and hemodiafiltration on T-wave-peak-to-end interval (Tpe) and Tpe/QT ratio of the surface electrocardiogram 2017
2016 Heme oxygenases in cardiovascular health and disease.  Physiological Reviews.  96:1449-1508. 2016
2016 Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury 2016
2016 Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram.  Geriatric Nephrology and Urology.  48:271-277. 2016
2016 Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells.  Journal of Cellular and Molecular Medicine.  20:217-230. 2016
2015 Macrophage and epithelial cell H-ferritin expression regulates renal inflammation.  Kidney International.  88:95-108. 2015
2014 Erratum to: Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis [Clinical and Experimental Nephrology, DOI 10.1007/s10157-014-0950-9].  Clinical and Experimental Nephrology.  18:960. 2014
2014 Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis.  Clinical and Experimental Nephrology.  18:952-959. 2014
2013 Proximal tubule h-ferritin mediates iron trafficking in acute kidney injury.  Journal of Clinical Investigation.  123:4423-4434. 2013
2013 Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cells 2013
2013 Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function.  BMC Nephrology.  14. 2013
2013 C-reactive protein exacerbates renal ischemia-reperfusion injury 2013
2012 Superoxide in AVF dysfunction: A new target for intervention 2012
2012 A reproducible mouse model of chronic allograft nephropathy with vasculopathy.  Kidney International.  82:1231-1235. 2012
2012 Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in mice.  Arthritis and Rheumatism.  64:4114-4124. 2012
2012 In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice.  Kidney International.  82:278-291. 2012
2012 Heme Oxygenase-1 as a Target for TGF-β in Kidney Disease.  Seminars in Nephrology.  32:277-286. 2012
2012 Enabling Innovative Translational Research in Acute Kidney Injury.  Clinical and Translational Science.  5:93-101. 2012
2011 Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells.  Kidney International.  80:731-739. 2011
2011 Sepsis and acute kidney injury.  Journal of the American Society of Nephrology.  22:999-1006. 2011
2011 ATP as a death factor: Purinergic signaling in renal epithelial-fibroblast cross talk 2011
2011 Identification of a microRNA signature in renal fibrosis: Role of miR-21 2011
2011 Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1 2011
2010 Ferritin ferroxidase activity: A potent inhibitor of osteogenesis.  Journal of Bone and Mineral Research.  25:164-172. 2010
2009 Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells.  Journal of the American Society of Nephrology.  20:1254-1263. 2009
2009 Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H2S).  Free Radical Biology and Medicine.  46:616-623. 2009

Chapter

Year Title Altmetric
2012 Ferritin/ferroxidase activity: A potent inhibitor of vascular calcification, osteoblastic transdifferentiation of vascular smooth muscle cells and osteoblast activity.  83-100. 2012

Education And Training

  • UAB Hospital, Residency
  • UAB Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, University of Debrecen 2006

    • Full Name

  • Abolfazl Zarjou